Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.190
+0.030 (2.59%)
At close: Jan 21, 2025, 4:00 PM
1.150
-0.040 (-3.36%)
After-hours: Jan 21, 2025, 7:59 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.47 million as of January 22, 2025. Its market cap has decreased by -7.08% in one year.
Market Cap
6.47M
Enterprise Value
2.37M
1-Year Change
-7.08%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.47M, a decrease of -99.44%. That is a compound annual growth rate of -76.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 6.47M | 2.59% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |